Clinical Trial
doi: 10.1159/000114633.
Effect of melanocyte-stimulating hormone-release inhibiting factor (MIF) in Parkinson's syndrom
- PMID: 4614981
- DOI: 10.1159/000114633
Item in Clipboard
Clinical Trial
Effect of melanocyte-stimulating hormone-release inhibiting factor (MIF) in Parkinson's syndrom
Eur Neurol.
1974.
No abstract available
Similar articles
-
Melanocyte-stimulating hormone-release inhibiting hormone as a antidepressant. A pilot study.Arch Gen Psychiatry. 1974 Jan;30(1):63-5. doi: 10.1001/archpsyc.1974.01760070047007. Arch Gen Psychiatry. 1974. PMID: 4587068 Clinical Trial. No abstract available.
-
Hypothalamic releasing factors and Parkinson disease.Arch Neurol. 1974 Jul;31(1):55-6. doi: 10.1001/archneur.1974.00490370081013. Arch Neurol. 1974. PMID: 4209275 No abstract available.
-
Parkinson's disease and amine metabolites in cerebrospinal fluid: implications for L-Dopa therapy.Eur Neurol. 1974;12(5-6):340-50. doi: 10.1159/000114631. Eur Neurol. 1974. PMID: 4448192 No abstract available.
-
Progress in understanding and treating Parkinson's disease.Can J Neurol Sci. 1976 May;3(2):81-4. doi: 10.1017/s0317167100025828. Can J Neurol Sci. 1976. PMID: 773522 Review.
-
Recent advances in the treatment of Parkinson's disease.J Am Osteopath Assoc. 1975 Apr;74(8):730-41. J Am Osteopath Assoc. 1975. PMID: 1092751 Review. No abstract available.
Cited by
-
Mass spectrometric quantification of MIF-1 in mouse brain by multiple reaction monitoring.Peptides. 2009 Jul;30(7):1276-81. doi: 10.1016/j.peptides.2009.04.004. Epub 2009 Apr 11. Peptides. 2009. PMID: 19540426 Free PMC article.
-
On the optimal dosage of Pro-Leu-Gly-NH2 (MIF) in neuropharmacological tests and clinical use.Naunyn Schmiedebergs Arch Pharmacol. 1977 Jun;298(2):79-81. doi: 10.1007/BF00508614. Naunyn Schmiedebergs Arch Pharmacol. 1977. PMID: 18686
-
Comparison of thyrotropin-releasing hormone with melanocyte-stimulating-hormone-release-inhibiting factor as pentobarbital antagonists in monkeys.Psychopharmacology (Berl). 1977 Jul 18;53(2):205-6. doi: 10.1007/BF00426494. Psychopharmacology (Berl). 1977. PMID: 19803
-
Concepts for biologically active peptides.Curr Pharm Des. 2010 Oct;16(30):3390-400. doi: 10.2174/138161210793563491. Curr Pharm Des. 2010. PMID: 20726835 Free PMC article. Review.
-
Stapling Amantadine to Melanostatin Neuropeptide: Discovery of Potent Positive Allosteric Modulators of the D2 Receptors.ACS Med Chem Lett. 2023 Nov 14;14(12):1656-1663. doi: 10.1021/acsmedchemlett.3c00264. eCollection 2023 Dec 14. ACS Med Chem Lett. 2023. PMID: 38116429 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
